Within Quay Pharma we can provide virtually all of the services required to bring drug products through the various stages of clinical development quickly and cost-effectively.
Quay Pharma has considerable experience in the development and manufacture of safe, robust conventional dosage forms including tablets, capsules, oral liquids and topical products.
The formulations we develop are supplied to the clients who commissioned them on a royalty-free basis. We are also used to working with formulations developed by clients or other contract manufacturers, and either optimising them or simply providing manufacturing support.
Where a substance shows particular solubility or bioavailability challenges, we can draw on a wide choice of innovative technologies to overcome the barriers to clinical progress. We can also provide a range of effective modified release technologies.
Conventional Dosage Forms
Tablets
Coated and uncoated modified release tablets in a wide range of shapes, sizes, finishes and release profiles.
Oral Liquids
Microparticles are suitable for a broad range of drug delivery applications, and they offer many advantages.
Capsules
Beads, pellets, granules or mini-tablets offer enormous flexibility in their drug release profiles.
Topical Products
Enhance systemic delivery by directing the release of the API to specific areas of the small intestine or colon.